Literature DB >> 6130947

Clinical studies with beta 2 adrenoceptor agonists in heart failure.

J R Dawson, J Bayliss, M S Norell, R Canepa-Anson, P Kuan, S Reuben, P A Poole-Wilson, G C Sutton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130947

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Alternatives to digitalis glycosides for heart failure.

Authors:  C G Wathen; A L Muir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-04

Review 2.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 3.  Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

4.  Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

Authors:  A Mügge; D Posselt; U Reimer; W Schmitz; H Scholz
Journal:  Klin Wochenschr       Date:  1985-01-02

5.  Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors:  D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal:  Br Heart J       Date:  1985-02

6.  Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.

Authors:  Manoraj Navaratnarajah; Urszula Siedlecka; Michael Ibrahim; Carin van Doorn; Gopal Soppa; Ajay Gandhi; Adarsh Shah; Punam Kukadia; Magdi H Yacoub; Cesare M Terracciano
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.